Effects of creatine supplementation on muscle weakness in patients with rheumatoid arthritis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Tiselius P. Studies on joint temperature, joint stiffness and muscle weakness in rheumatoid arthritis: an experimental and clinical investigation. Acta Rheumatol Scand1969;(Suppl. 14):70–98.
Ekblom B, Lövgren O, Alderin M, Fridström M, Sätterström G. Physical performance in patients with rheumatoid arthritis. Scand J Rheumatol1974;3:121–5.
Nordesjö LO, Nordgren B, Wigren A, Kolstad K. Isometric strength and endurance in patients with severe rheumatoid arthritis or osteoarthrosis in knee joints. Scand J Rheumatol1983;12:152–6.
Ekdahl C, Andersson SI, Svensson B. Muscle function of the lower extremities in rheumatoid arthritis and osteoarthrosis: A descriptive study of patients in a primary health care district. J Clin Epidemiol1989;42:947–54.
Stucki G, Schönbächler J, Brühlmann P, Mariacher S, Stoll T, Michel BA. Does a muscle strength index provide complementary information to traditional disease activity variables in patients with rheumatoid arthritis? J Rheumatol1994;21:2200–5.
Halla JT, Koopman WJ, Fallahi S, Oh SJ, Gay RE, Schrohenloher RE. Rheumatoid myositis. Clinical and histologic features and possible pathogenesis. Arthritis Rheum1984;27:737–43.
Wortmann RL. Inflammatory diseases of muscle. In: Kelley WN, ed. Textbook of rheumatology, 4th edn. Philadelphia: WB Saunders Company, 1993:1159–88.
Sanmarti R, Collado A, Gratocos J et al. Reduced activity of serum creatine kinase in rheumatoid arthritis: a phenomenon linked to the inflammatory response. Br J Rheumatol1994;33:231–4.
Stucki G, Brühlmann P, Stoll T, Stucki S, Willer B, Michel BA. Reduced serum creatine kinase activity is associated with muscle weakness in patients with rheumatoid arthritis. J Rheumatol1996;23:603–8.
Vannas‐Sulonen K, Sipila I, Vannas A, Simell O, Rapola J. Gyrate atrophy of the choroid and retina. A five‐year follow‐up of creatinine supplementation. Ophthalmology1985;92:1719–27.
Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subject by creatine supplementation. Clin Sci1992;83:367–74.
Greenhaff PL, Bodin K, Soderland K, Hultman. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol1994;266:E725–30.
Gordon A, Hultman E, Kaijser L et al. Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovascular Res1995;30:413–8.
Hultman E, Söderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. J Appl Physiol1996;81:232–7.
Vandenberghe K, Gillis N, Van Leemputte M, Van Hecke P, Vanstapel F, Hespel P. Caffeine counteracts the ergogenic action of muscle creatine loading. J Appl Physiol1996;80:452–7.
Vandenberghe K, Goris M, Van Hecke P, Van Leemputte M, Vangerven L, Hespel P. Long‐term creatine intake is beneficial to muscle performance during resistance training. J Appl Physiol1997;83:2055–63.
Greenhaff PL, Casey A, Short AH, Harris R, Soderlund K. Influence of oral creatine supplementation of muscle torque during repeated bouts of maximal voluntary exercise in man. Clin Sci1993;84:565–71.
Earnest CP, Snell PG, Rodrguez R, Almada AL, Mitchell TL. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand1995;153:207–9.
Stroud MA, Holliman D, Bell D, Green AL, MacDonald IA, Greenhaff PL. Effect of oral creatine supplementation on respiratory gas exchange and blood lactate accumulation during steady‐state incremental treadmill exercise and recovery in man. Clin Sci1994;87:707–10.
Cooke WH, Grandjean PW, Barnes WS. Effect of oral creatine supplementation on power output and fatigue during bicycle ergometry. J Appl Physiol1995;78:670–3.
Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988;31:315.
Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum1980;23:137–45.
Brühlmann P, Stucki G, Michel BA. Evaluation of a German version of the physical dimension of the health assessment questionnaire in patients with rheumatoid arthritis. J Rheumatol1994;21:1245–9.
van der Heijde DMFM, van't Hof MA, van Riel PLCM, van Leeuwen MA, van Rijswijk MH, van de Putte LBA. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis1992;51:177–81.
Mason JH, Anderson JJ, Meenan RF, Haralson KM, Lewis‐Stevens D, Kaine JL. The rapid assessment of disease activity in rheumatology (RADAR) questionnaire. Validity and sensitivity to change of a patient self‐report measure of joint count and clinical status. Arthritis Rheum1992;35:156–62.
Bernt E, Bergmeyer HU, Möllering H. Creatine. In: Bergmeyer HU, ed. Methods of enzymatic analysis, 2nd edn. Weinheim: Wiley 1974:1772–6.
Lamprecht W, Stein P, Heinz F, Weisser H. Creatine phosphate. In: Bergmeyer HU, ed. Methods of enzymatic analysis, 2nd edn. Weinheim: Wiley 1974:1777–83.
In: Wissenschaftliche Tabellen Geigy, Geigy (Hrsg.): Teilband Körperflüssigkeiten. Achte, revidierte und erweiterte Auflage. 8th edn. Basel, 1977:216.